Schiff base ligands and their 3d-metal chelates have gained significant attention due to various applications in various scientific platforms. Due to their chelating propensity, they possess a wide range of biological, biochemical, catalytic, clinical, dying, and pharmacological properties. Here, in present studies, two novel Ni(II) and Zn(II) transition metal chelates have been synthesized by condensing their metal salts with Schiff base ligand 4-chloro-2-(2,5-dimethoxybenzylideneamino)-5-nitrophenol originated from 2,5-dimethoxybenzaldehyde and 2-amino-4-chloro-5-nitrophenol. The synthesized Schiff base ligand and its metal chelates have been Spectro-chemically examined by FT-IR, UV-Vis absorption spectroscopy, Mass Spectrometry, ¹HNMR, Thermogravimetric analysis (TGA) and Powdered-XRD. These compounds are biologically reactive and exhibit antifungal, antioxidant, and DNA-binding activity. The Ni(II) metal chelate gives better biological activity than the Zn(II) metal chelate and parent Schiff base ligand.
No takes yet. Share an insight, caveat, or question.
Varshney et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: